Safety and immunogenicity of haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age
- 1 February 1985
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 106 (2), 185-189
- https://doi.org/10.1016/s0022-3476(85)80284-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Safety and Immunogenicity of Haemophilus influenzae Type B Polysaccharide-Diphtheria Toxoid Conjugate Vaccine in AdultsThe Journal of Infectious Diseases, 1984
- Immunogenicity of Haemophilus influenzae type b polysaccharide—diphtheria toxoid conjugate vaccine in adultsThe Journal of Pediatrics, 1984
- Prevention ofHemophilus influenzaeType B Bacteremic Infections with the Capsular Polysaccharide VaccineNew England Journal of Medicine, 1984
- Antibody responses to meningococcal polysaccharide vaccine in adults without a spleenAmerican Journal Of Medicine, 1984
- Spread of Haemophilus influenzae type b: Recent epidemiologic and therapeutic considerationsThe Journal of Pediatrics, 1980
- Haemophilus influenzae Type b Capsular Polysaccharide Vaccine in Children: A Double-Blind Field Study of 100,000 Vaccinees 3 Months to 5 Years of Age in FinlandPediatrics, 1977
- HEMOPHILUS-INFLUENZAE TYPE-B CAPSULAR POLYSACCHARIDE VACCINE IN CHILDREN - DOUBLE-BLIND FIELD-STUDY OF 100,000 VACCINEES 3 MONTHS TO 5 YEARS OF AGE IN FINLAND1977
- Quantitative Measurement of “Natural” and Immunization-induced Haemophilus influenzas type b Capsular Polysaccharide AntibodiesPediatric Research, 1973